Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13133)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2014 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li TT, Ogino S, Qian ZR. Toll-like receptor signaling in colorectal cancer: Carcinogenesis to cancer therapy. World J Gastroenterol 2014; 20(47): 17699-17708 [PMID: 25548469 DOI: 10.3748/wjg.v20.i47.17699] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i47/17699.htm |
| Number | Citing Articles |
| 1 |
Miaohua Liu, Fuchun Liu, Yuanle Pan, Yi Xiong, Xin Zeng, LinXin Zheng, Haimei Zhao, Yanzhen Li, Duanyong Liu. Oxymatrine ameliorated experimental colitis via mechanisms involving inflammatory DCs, gut microbiota and TLR/NF-κB pathway. International Immunopharmacology 2023; 115: 109612 doi: 10.1016/j.intimp.2022.109612
|
| 2 |
Reyhaneh Moradi‐Marjaneh, Seyed Mahdi Hassanian, Hamid Fiuji, Saman Soleimanpour, Gordon A. Ferns, Amir Avan, Majid Khazaei. Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer. Journal of Cellular Physiology 2018; 233(8): 5613 doi: 10.1002/jcp.26273
|
| 3 |
Sharad Singh Lodhi, Manish Sinha, Yogesh K. Jaiswal, Gulshan Wadhwa. Current trends in Bioinformatics: An Insight. 2018; : 145 doi: 10.1007/978-981-10-7483-7_8
|
| 4 |
Pachiyappan Kamarajan, Islam Ateia, Jae M. Shin, J. Christopher Fenno, Charles Le, Ling Zhan, Ana Chang, Richard Darveau, Yvonne L. Kapila, Renée M. Tsolis. Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin. PLOS Pathogens 2020; 16(10): e1008881 doi: 10.1371/journal.ppat.1008881
|
| 5 |
Qianying Lu, Sifan Yu, Xiangyan Meng, Mingyu Shi, Siyu Huang, Junfeng Li, Jianfeng Zhang, Yangfan Liang, Mengjun Ji, Yanmei Zhao, Haojun Fan. MicroRNAs: Important Regulatory Molecules in Acute Lung Injury/Acute Respiratory Distress Syndrome. International Journal of Molecular Sciences 2022; 23(10): 5545 doi: 10.3390/ijms23105545
|
| 6 |
Sumel Ashique, Mithun Bhowmick, Radheshyam Pal, Heya Khatoon, Prashant Kumar, Himanshu Sharma, Ashish Garg, Shubneesh Kumar, Ushasi Das. Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success. Advances in Cancer Biology - Metastasis 2024; 10: 100114 doi: 10.1016/j.adcanc.2024.100114
|
| 7 |
Shengwei Han, Wenguang Xu, Zhiyong Wang, Xiaofeng Qi, Yufeng Wang, Yanhong Ni, Hao Shen, Qingang Hu, Wei Han. Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment. Oncotarget 2016; 7(25): 37773 doi: 10.18632/oncotarget.9329
|
| 8 |
Saran Aravinda Chandrasekar, Thirunavukkarasu Palaniyandi, Udhayakumar Parthasarathy, Hemapreethi Surendran, Sandhiya Viswanathan, Mugip Rahaman Abdul Wahab, Gomathy Baskar, Sudhakar Natarajan, Kishu Ranjan. Implications of Toll-like receptors (TLRs) and their signaling mechanisms in human cancers. Pathology - Research and Practice 2023; 248: 154673 doi: 10.1016/j.prp.2023.154673
|
| 9 |
Na Dong, Xinran Li, Chenyu Xue, Lei Zhang, Chensi Wang, Xinyao Xu, Anshan Shan. Astragalus polysaccharides alleviates LPS‐induced inflammation via the NF‐κB/MAPK signaling pathway. Journal of Cellular Physiology 2020; 235(7-8): 5525 doi: 10.1002/jcp.29452
|
| 10 |
Tianzhen Wang, Guangyu Wang, Dapeng Hao, Xi Liu, Dong Wang, Ning Ning, Xiaobo Li. Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0402-5
|
| 11 |
Pradipta Maji, Ekta Shah, Sushmita Paul. RelSim: An integrated method to identify disease genes using gene expression profiles and PPIN based similarity measure. Information Sciences 2017; 384: 110 doi: 10.1016/j.ins.2016.06.034
|
| 12 |
Xiaopei Huang, Yijun Tian, Wenjing Shi, Jikuai Chen, Lang Yan, Lijun Ren, Xiaofang Zhang, Jiangbo Zhu. Role of inflammation in the malignant transformation of pleural mesothelial cells induced by multi-walled carbon nanotubes. Nanotoxicology 2020; 14(7): 947 doi: 10.1080/17435390.2020.1777477
|
| 13 |
Apryl S. Saunders, Dawn E. Bender, Anita L. Ray, Xiangyan Wu, Katherine T. Morris, Salvatore V Pizzo. Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data. PLOS ONE 2021; 16(2): e0247233 doi: 10.1371/journal.pone.0247233
|
| 14 |
Satoshi Okazaki, Fotios Loupakis, Sebastian Stintzing, Shu Cao, Wu Zhang, Dongyun Yang, Yan Ning, Yu Sunakawa, Stefan Stremitzer, Satoshi Matsusaka, Martin D. Berger, Anish Parekh, Jordan D. West, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Chiara Cremolini, Alfredo Falcone, Volker Heinemann, R. William DePaolo, Heinz-Josef Lenz. Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab. Molecular Cancer Therapeutics 2016; 15(7): 1740 doi: 10.1158/1535-7163.MCT-15-0931
|
| 15 |
Andrzej Hnatyszyn, Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Emilia Lis, Ryszard Słomski, Rodney J. Scott, Andrzej Pławski. Colorectal carcinoma in the course of inflammatory bowel diseases. Hereditary Cancer in Clinical Practice 2019; 17(1) doi: 10.1186/s13053-019-0118-4
|
| 16 |
Yahui Zhu, Li Gu, Xi Lin, Jinmiao Zhang, Yi Tang, Xinyi Zhou, Bingjun Lu, Xingrong Lin, Cheng Liu, Edward V. Prochownik, Youjun Li. Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice. JCI Insight 2022; 7(3) doi: 10.1172/jci.insight.150607
|
| 17 |
Yong Chai, Yunyan Du, Shouhua Zhang, Juhua Xiao, Zhipeng Luo, Fei He, Kai Huang. MicroRNA-485-5p reduces O-GlcNAcylation of Bmi-1 and inhibits colorectal cancer proliferation. Experimental Cell Research 2018; 368(1): 111 doi: 10.1016/j.yexcr.2018.04.020
|
| 18 |
Yi Wang, Kai Conrad Cecil Johnson, Margaret E. Gatti-Mays, Zihai Li. Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy. Journal of Hematology & Oncology 2022; 15(1) doi: 10.1186/s13045-022-01335-y
|
| 19 |
Hao Sun, Yingmei Li, Peng Zhang, Haizhou Xing, Song Zhao, Yongping Song, Dingming Wan, Jifeng Yu. Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives. Biomarker Research 2022; 10(1) doi: 10.1186/s40364-022-00436-7
|
| 20 |
Janaina L. S. Donadio, Samira Bernardino Ramos do Prado, Marcelo M. Rogero, João Paulo Fabi. Effects of pectins on colorectal cancer: targeting hallmarks as a support for future clinical trials. Food & Function 2022; 13(22): 11438 doi: 10.1039/D2FO01995G
|
| 21 |
Jingchun Qin, Huixuan Li, Weitao Yu, Li Wei, Bin Wen. Effect of cold exposure and capsaicin on the expression of histone acetylation and Toll-like receptors in 1,2-dimethylhydrazine-induced colon carcinogenesis. Environmental Science and Pollution Research 2021; 28(43): 60981 doi: 10.1007/s11356-021-14849-8
|
| 22 |
Simon Bernard Iloki Assanga, Lidianys María Lewis Luján, Mark F. McCarty. Targeting beta-catenin signaling for prevention of colorectal cancer – Nutraceutical, drug, and dietary options. European Journal of Pharmacology 2023; 956: 175898 doi: 10.1016/j.ejphar.2023.175898
|
| 23 |
Vincenzo Giambra, Danilo Pagliari, Pierluigi Rio, Beatrice Totti, Chiara Di Nunzio, Annalisa Bosi, Cristina Giaroni, Antonio Gasbarrini, Giovanni Gambassi, Rossella Cianci. Gut Microbiota, Inflammatory Bowel Disease, and Cancer: The Role of Guardians of Innate Immunity. Cells 2023; 12(22): 2654 doi: 10.3390/cells12222654
|
| 24 |
Mao Wang, Alex Gauthier, LeeAnne Daley, Katelyn Dial, Jiaqi Wu, Joanna Woo, Mosi Lin, Charles Ashby, Lin L. Mantell. The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases. Antioxidants & Redox Signaling 2019; 31(13): 954 doi: 10.1089/ars.2019.7818
|
| 25 |
Matheus Loureiro da Silva Cruz, Rafael Pereira dos Santos, Barbara Kunzler Souza, Mariane da Cunha Jaeger, Camila Alves da Silva, Lauro José Gregianin, Jiseh Fagundes Loss, Rebeca Ferreira Marques, Algemir Lunardi Brunetto, André Tesainer Brunetto, Rafael Roesler, Caroline Brunetto de Farias. Toll-like Receptors 2, 3, and 4 in Childhood Acute Lymphocytic Leukemia. Revista Brasileira de Cancerologia 2023; 69(3) doi: 10.32635/2176-9745.RBC.2023v69n3.3676
|
| 26 |
Mahnoor Majid, Saadia Andleeb. Designing a multi-epitopic vaccine against the enterotoxigenic Bacteroides fragilis based on immunoinformatics approach. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-55613-w
|
| 27 |
Samira Bernardino Ramos do Prado, Victor Costa Castro-Alves, Gabrielle Fernandez Ferreira, João Paulo Fabi. Ingestion of Non-digestible Carbohydrates From Plant-Source Foods and Decreased Risk of Colorectal Cancer: A Review on the Biological Effects and the Mechanisms of Action. Frontiers in Nutrition 2019; 6 doi: 10.3389/fnut.2019.00072
|
| 28 |
Saleh Almasabi, Afsar U. Ahmed, Richard Boyd, Bryan R. G. Williams. A Potential Role for Integrin-Linked Kinase in Colorectal Cancer Growth and Progression via Regulating Senescence and Immunity. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.638558
|
| 29 |
Maria Dobre, Bogdan Trandafir, Elena Milanesi, Alessandro Salvi, Ioana Alina Bucuroiu, Catalin Vasilescu, Andrei Marian Niculae, Vlad Herlea, Mihail Eugen Hinescu, Gabriel Constantinescu. Molecular profile of the NF‐κB signalling pathway in human colorectal cancer. Journal of Cellular and Molecular Medicine 2022; 26(24): 5966 doi: 10.1111/jcmm.17545
|
| 30 |
Alvaro G. Alvarado, Justin D. Lathia. Taking a Toll on Self-Renewal: TLR-Mediated Innate Immune Signaling in Stem Cells. Trends in Neurosciences 2016; 39(7): 463 doi: 10.1016/j.tins.2016.04.005
|
| 31 |
Yun Yang, Rang Feng, Yuan-Zhong Wang, Hong-Wu Sun, Quan-Ming Zou, Hai-Bo Li. Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy. Immunology Letters 2020; 223: 1 doi: 10.1016/j.imlet.2020.04.002
|
| 32 |
Mina Shahnazari, Pouria Samadi, Mona Pourjafar, Akram Jalali. Cell-based immunotherapy approaches for colorectal cancer: main achievements and challenges. Future Oncology 2021; 17(24): 3253 doi: 10.2217/fon-2020-1218
|
| 33 |
Yuqi Wang, Hongwei Yuan, Genquan Yue, Lingyan Zhao, Yuan Xia, Nan Zhang, Hailing Li, Dongyang Liu, Yubo Su, Haisheng Wang, Yumin Gao. Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-27602-7
|
| 34 |
R. Braster, M. Bögels, R.H.J. Beelen, M. van Egmond. The delicate balance of macrophages in colorectal cancer; their role in tumour development and therapeutic potential. Immunobiology 2017; 222(1): 21 doi: 10.1016/j.imbio.2015.08.011
|
| 35 |
Wenbin Dai, Longhai Long, Xiaoqiang Wang, Sen Li, Houping Xu. Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease. Chinese Medicine 2022; 17(1) doi: 10.1186/s13020-022-00611-w
|
| 36 |
S.Y. Lam, J. Yu, S.H. Wong, M.P. Peppelenbosch, G.M. Fuhler. The gastrointestinal microbiota and its role in oncogenesis. Best Practice & Research Clinical Gastroenterology 2017; 31(6): 607 doi: 10.1016/j.bpg.2017.09.010
|
| 37 |
Yang Jiang, Jinpeng Zhou, Peng Luo, Huiling Gao, Yanju Ma, Yin-Sheng Chen, Long Li, Dan Zou, Ye Zhang, Zhitao Jing. Prosaposin promotes the proliferation and tumorigenesis of glioma through toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway. EBioMedicine 2018; 37: 78 doi: 10.1016/j.ebiom.2018.10.053
|
| 38 |
Qingsong Tang, E. Xu, Zhikang Wang, Mingfei Xiao, Shuting Cao, Shenglan Hu, Qiwen Wu, Yunxia Xiong, Zongyong Jiang, Fengying Wang, Geling Yang, Li Wang, Hongbo Yi. Dietary Hermetia illucens Larvae Meal Improves Growth Performance and Intestinal Barrier Function of Weaned Pigs Under the Environment of Enterotoxigenic Escherichia coli K88. Frontiers in Nutrition 2022; 8 doi: 10.3389/fnut.2021.812011
|
| 39 |
Sheng Lu, Zheng-Gang Zhu, Wen-Cong Lu. Inferring novel genes related to colorectal cancer via random walk with restart algorithm. Gene Therapy 2019; 26(9): 373 doi: 10.1038/s41434-019-0090-7
|
| 40 |
Ga‐Bin Park, Jee‐Yeong Jeong, Daejin Kim. Modified TLR‐mediated downregulation of miR‐125b‐5p enhances CD248 (endosialin)‐induced metastasis and drug resistance in colorectal cancer cells. Molecular Carcinogenesis 2020; 59(2): 154 doi: 10.1002/mc.23137
|
| 41 |
Omar Al-Obeed, Adila Salih El-Obeid, Sabine Matou-Nasri, Mansoor-Ali Vaali-Mohammed, Yazeid AlHaidan, Mohammed Elwatidy, Hamad Al Dosary, Zeyad Alehaideb, Khayal Alkhayal, Adil Haseeb, James McKerrow, Rehan Ahmad, Maha-Hamadien Abdulla. Herbal melanin inhibits colorectal cancer cell proliferation by altering redox balance, inducing apoptosis, and modulating MAPK signaling. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01206-x
|
| 42 |
Mingde Cao, Junhui Zhang, Hualiang Xu, Zhujian Lin, Hong Chang, Yuchen Wang, Xusheng Huang, Xiang Chen, Hua Wang, Yancheng Song. Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.608368
|
| 43 |
T. M. Sokolova, V. V. Poloskov, O. S. Burova, A. N. Shuvalov, Z. A. Sokolova, A. N. Inshakov, Yu. V. Shishkin, F. I. Ershov. ACTION INTERFERONS AND IFN-INDUCTORS ON TLR/RLRS GENES EXPRESSION AND DIFFERENTIATION OF TUMOR CELL LINES THP-1 AND HCT-116. Russian Journal of Biotherapy 2016; 15(3): 28 doi: 10.17650/1726-9784-2016-15-3-28-33
|
| 44 |
Chen Shuang, Yuan Weiguang, Fu Zhenkun, Huang Yike, Yang Jiankun, Xue Jing, Liu Xinghan, Li Yue, Li Dalin. Toll-like receptor 5 gene polymorphism is associated with breast cancer susceptibility. Oncotarget 2017; 8(51): 88622 doi: 10.18632/oncotarget.20242
|
| 45 |
Wenhao Weng, Ajay Goel. Curcumin and colorectal cancer: An update and current perspective on this natural medicine. Seminars in Cancer Biology 2022; 80: 73 doi: 10.1016/j.semcancer.2020.02.011
|
| 46 |
Wang Gang, Jun‐Jie Wang, Rui Guan, Sun Yan, Feng Shi, Jia‐Yan Zhang, Zi‐Meng Li, Jing Gao, Xing‐Li Fu. Strategy to targeting the immune resistance and novel therapy in colorectal cancer. Cancer Medicine 2018; 7(5): 1578 doi: 10.1002/cam4.1386
|
| 47 |
Nada Oršolić, Maja Jazvinšćak Jembrek. Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer. International Journal of Molecular Sciences 2022; 23(18): 10479 doi: 10.3390/ijms231810479
|
| 48 |
Xuehai Jia, Ke Zhang, Shushu Feng, Yuyao Li, Dahong Yao, Qiaohui Liu, Dong Liu, Xin Li, Jian Huang, Hangyu Wang, Jinhui Wang. Total glycosides of Rhodiola rosea L. attenuate LPS-induced acute lung injury by inhibiting TLR4/NF-κB pathway. Biomedicine & Pharmacotherapy 2023; 158: 114186 doi: 10.1016/j.biopha.2022.114186
|
| 49 |
Bo Chang, Seon Kim, Mi Lee, Hyun Park, Sung Kim. Improved Chemotherapeutic Activity by Morus alba Fruits through Immune Response of Toll-Like Receptor 4. International Journal of Molecular Sciences 2015; 16(10): 24139 doi: 10.3390/ijms161024139
|
| 50 |
Panida Sittipo, Stefani Lobionda, Kyungchul Choi, Ita Novita Sari, Hyog Young Kwon, Yun Kyung Lee. Toll-Like Receptor 2-Mediated Suppression of Colorectal Cancer Pathogenesis by Polysaccharide A From Bacteroides fragilis. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.01588
|
| 51 |
Sama Rezasoltani, Reza Ghanbari, Mehdi Azizmohammad Looha, Ehsan Nazemalhosseini Mojarad, Abbas Yadegar, Delisha Stewart, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali. Expression of Main Toll-Like Receptors in Patients with Different Types of Colorectal Polyps and Their Relationship with Gut Microbiota. International Journal of Molecular Sciences 2020; 21(23): 8968 doi: 10.3390/ijms21238968
|
| 52 |
Liangmei He, Yayun Chen, Yuanbing Wu, Ying Xu, Zixiang Zhang, Zhiping Liu. Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis. Cellular and Molecular Life Sciences 2017; 74(13): 2395 doi: 10.1007/s00018-017-2477-1
|
| 53 |
Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, Andrea Masotti, Alessandro Paolini, Meysam Sarshar. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1244345
|
| 54 |
Yingxin Yu, Bart Blokhuis, Yvonne Derks, Sangeeta Kumari, Johan Garssen, Frank Redegeld. Human mast cells promote colon cancer growth via bidirectional crosstalk: studies in 2D and 3D coculture models. OncoImmunology 2018; 7(11) doi: 10.1080/2162402X.2018.1504729
|
| 55 |
Lu Lu, Jiahuan Dong, Yujing Liu, Yufan Qian, Guangtao Zhang, Wenjun Zhou, Aiguang Zhao, Guang Ji, Hanchen Xu. New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.964793
|
| 56 |
Yinan Li, Wei Yang, Bin Wu, Yaqing Liu, Dongbei Li, Yantong Guo, Haiying Fu, Yi Li. KDM3A promotes inhibitory cytokines secretion by participating in TLR4 regulation of Foxp3 transcription in lung adenocarcinoma cells. Oncology Letters 2017; 13(5): 3529 doi: 10.3892/ol.2017.5949
|
| 57 |
Su-Min Lim, Hyo-Min Jang, Jin-Ju Jeong, Myung Joo Han, Dong-Hyun Kim. Lactobacillus johnsonii CJLJ103 attenuates colitis and memory impairment in mice by inhibiting gut microbiota lipopolysaccharide production and NF-κB activation. Journal of Functional Foods 2017; 34: 359 doi: 10.1016/j.jff.2017.05.016
|
| 58 |
S.M. Nashir Udden, Lan Peng, Jia-Liang Gan, John M. Shelton, James S. Malter, Lora V. Hooper, Md. Hasan Zaki. NOD2 Suppresses Colorectal Tumorigenesis via Downregulation of the TLR Pathways. Cell Reports 2017; 19(13): 2756 doi: 10.1016/j.celrep.2017.05.084
|
| 59 |
Yizhong Ji, Xucan Tu, Xiuqi Hu, Zhenglin Wang, Sifan Gao, Qifan Zhang, Wei Zhang, Huabing Zhang, Wei Chen. The role and mechanism of action of RNF186 in colorectal cancer through negative regulation of NF-κB. Cellular Signalling 2020; 75: 109764 doi: 10.1016/j.cellsig.2020.109764
|
| 60 |
Alicja Pakiet, Jarosław Kobiela, Piotr Stepnowski, Tomasz Sledzinski, Adriana Mika. Changes in lipids composition and metabolism in colorectal cancer: a review. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-0977-8
|
| 61 |
MAMDOOH GHONEUM, NOURAN FELO. Selective induction of apoptosis in human gastric cancer cells by Lactobacillus kefiri (PFT), a novel kefir product. Oncology Reports 2015; 34(4): 1659 doi: 10.3892/or.2015.4180
|
| 62 |
Shuai Wang, Lili Zhou, Li Ling, Xuli Meng, Feng Chu, Suping Zhang, Fangfang Zhou. The Crosstalk Between Hippo-YAP Pathway and Innate Immunity. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00323
|
| 63 |
Han Shuwen, Yang Xi, Qi Quan, Pan Yuefen, Da Miao, Zhou Qing. Relationship between intestinal microorganisms and T lymphocytes in colorectal cancer. Future Oncology 2019; 15(14): 1655 doi: 10.2217/fon-2018-0595
|
| 64 |
Weichang Yang, Zhouhua Li, Wenjun Wang, Juan Wu, Xiaoqun Ye. Five-hub genes identify potential mechanisms for the progression of asthma to lung cancer. Medicine 2023; 102(6): e32861 doi: 10.1097/MD.0000000000032861
|
| 65 |
Veronika Holubekova, Dusan Loderer, Marian Grendar, Peter Mikolajcik, Zuzana Kolkova, Eva Turyova, Eva Kudelova, Michal Kalman, Juraj Marcinek, Juraj Miklusica, Ludovit Laca, Zora Lasabova. Differential gene expression of immunity and inflammation genes in colorectal cancer using targeted RNA sequencing. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1206482
|
| 66 |
Gitana Maria Aceto, Teresa Catalano, Maria Cristina Curia. Molecular Aspects of Colorectal Adenomas: The Interplay among Microenvironment, Oxidative Stress, and Predisposition. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1726309
|
| 67 |
Jingxin Ma, Qi Wei, Xin Cheng, Jie Zhang, Zhongtao Zhang, Jianrong Su. Potential role of gut microbes in the efficacy and toxicity of immune checkpoints inhibitors. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1170591
|
| 68 |
Patrice D. Cani, Benedicte F. Jordan. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nature Reviews Gastroenterology & Hepatology 2018; 15(11): 671 doi: 10.1038/s41575-018-0025-6
|
| 69 |
Lucia Scarabel, Alessia Bignucolo, Giuseppe Toffoli, Erika Cecchin, Elena De Mattia. Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC. Pharmaceutics 2022; 14(11): 2468 doi: 10.3390/pharmaceutics14112468
|
| 70 |
Shuang Wu, Yuzhu Gong, Jianfang Chen, Xiang Zhao, Huimin Qing, Yan Dong, Sisi Li, Jianjun Li, Zhe Wang. Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma. Biology Direct 2022; 17(1) doi: 10.1186/s13062-022-00332-y
|
| 71 |
Lu Wang, Kewei Yu, Xiang Zhang, Shuwen Yu. Dual functional roles of the MyD88 signaling in colorectal cancer development. Biomedicine & Pharmacotherapy 2018; 107: 177 doi: 10.1016/j.biopha.2018.07.139
|
| 72 |
Noha A. El-Boghdady, Shrook Abd El-Hakk, Mai A. Abd-Elmawla. The lncRNAs UCA1 and CRNDE target miR-145/TLR4/NF-қB/TNF-α axis in acetic acid-induced ulcerative colitis model: The beneficial role of 3,3-Diindolylmethane. International Immunopharmacology 2023; 121: 110541 doi: 10.1016/j.intimp.2023.110541
|
| 73 |
Jing Xu, Xinxin Zhang, Mingming Zhou, Peizhe Lu, Yuting Xu, Lihong Wu, Qianyue Zhang, Zhihua Wu, Xiaoyu Xu, Pengfei Shi, Qingda Wei, Xiaoyu Li, Qiaoling Song. Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1132265
|
| 74 |
Małgorzata Guz, Witold Jeleniewicz, Anna Malm, Izabela Korona-Glowniak. A Crosstalk between Diet, Microbiome and microRNA in Epigenetic Regulation of Colorectal Cancer. Nutrients 2021; 13(7): 2428 doi: 10.3390/nu13072428
|
| 75 |
Tengfei Xiao, Mingzhong Sun, Yi Chang, Jingjing Kang, Chuanxiang Zhao, Rong Zhu, Hongmei Chen, Yetao Qiang. Butyrate impeded the conscription of MDSCs to reduce CAC formation by blocking the TLR2 signaling pathway. Journal of Functional Foods 2022; 99: 105344 doi: 10.1016/j.jff.2022.105344
|
| 76 |
Almudena Espín-Pérez, Laia Font-Ribera, Karin van Veldhoven, Julian Krauskopf, Lutzen Portengen, Marc Chadeau-Hyam, Roel Vermeulen, Joan O. Grimalt, Cristina M. Villanueva, Paolo Vineis, Manolis Kogevinas, Jos C. Kleinjans, Theo M. de Kok. Blood transcriptional and microRNA responses to short-term exposure to disinfection by-products in a swimming pool. Environment International 2018; 110: 42 doi: 10.1016/j.envint.2017.10.003
|
| 77 |
Wu Yinhang, Wu Wei, Zhuang Jing, Zhou Qing, Zhou Yani, Wang Yangyanqiu, Han Shuwen. Biological roles of toll-like receptors and gut microbiota in colorectal cancer. Future Microbiology 2022; 17(13): 1071 doi: 10.2217/fmb-2021-0072
|
| 78 |
Sugong Chen, Robert C. Fisher, Steven Signs, L. Alex Molina, Anitha K. Shenoy, Maria-Cecilia Lopez, Henry V. Baker, John M. Koomen, Yi Chen, Haley Gittleman, Jill Barnholtz-Sloan, Annamarie Berg, Henry D. Appelman, Emina H. Huang. Inhibition of PI3K/Akt/mTOR signaling in PI3KR2-overexpressing colon cancer stem cells reduces tumor growth due to apoptosis. Oncotarget 2017; 8(31): 50476 doi: 10.18632/oncotarget.9919
|
| 79 |
Marin Golčić, Andrej Belančić. Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?. Diabetology 2023; 4(4): 553 doi: 10.3390/diabetology4040049
|
| 80 |
E. A. Dzhenkova, E. A. Mirzoyan, A. B. Sagakyants, E. S. Bondarenko, E. Yu. Zlatnik, A. V. Shaposhnikov, E. N. Kolesnikov, O. Yu. Kaymakchi, A. V. Dashkov, G. V. Kaminskiy, A. G. Milakin, S. A. Malinin, D. A. Savchenko, L. Kh. Chalkhakhyan. Evaluation of Toll-like receptors expression in terms of colon cancer. Research and Practical Medicine Journal 2022; 9(4): 63 doi: 10.17709/2410-1893-2022-9-4-6
|
| 81 |
Cécily Lucas, Nicolas Barnich, Hang Nguyen. Microbiota, Inflammation and Colorectal Cancer. International Journal of Molecular Sciences 2017; 18(6): 1310 doi: 10.3390/ijms18061310
|
| 82 |
Kumar Vijay. Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. International Immunopharmacology 2018; 59: 391 doi: 10.1016/j.intimp.2018.03.002
|
| 83 |
Huarong Zhang, Junling Wu, Daihan Ji, Yijuan Liu, Shuting Lu, Zeman Lin, Ting Chen, Lu Ao. Microbiome analysis reveals universal diagnostic biomarkers for colorectal cancer across populations and technologies. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1005201
|
| 84 |
Fengyuan Che, Jiawei Yin, Yanchun Quan, Xiaoli Xie, Xueyuan Heng, Yifeng Du, Lijuan Wang. TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis. Oncotarget 2017; 8(32): 53495 doi: 10.18632/oncotarget.18586
|
| 85 |
Yun‐Jie Shi, Quan‐Quan Zhao, Xiao‐Shuang Liu, Su‐He Dong, Ji‐Fu E, Xu Li, Cong Liu, Hao Wang. Toll‐like receptor 4 regulates spontaneous intestinal tumorigenesis by up‐regulating IL‐6 and GM‐CSF. Journal of Cellular and Molecular Medicine 2020; 24(1): 385 doi: 10.1111/jcmm.14742
|
| 86 |
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Farid Hashemi, Fardin Hashemi, Saeed Samarghandian, Masoud Najafi. MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer. Life Sciences 2020; 256: 117973 doi: 10.1016/j.lfs.2020.117973
|
| 87 |
Aga Syed Sameer, Saniya Nissar, Burak Durmaz. Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/1157023
|
| 88 |
Vinita Mishra, Chandramani Pathak. Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer. International Journal of Biological Macromolecules 2019; 122: 425 doi: 10.1016/j.ijbiomac.2018.10.142
|
| 89 |
Ragna M.S. Haegebaert, Maxime Kempers, Wim Ceelen, Ine Lentacker, Katrien Remaut. Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer. European Journal of Pharmaceutics and Biopharmaceutics 2022; 172: 16 doi: 10.1016/j.ejpb.2022.01.002
|
| 90 |
Marc J. Braunstein, John Kucharczyk, Sylvia Adams. Targeting Toll-Like Receptors for Cancer Therapy. Targeted Oncology 2018; 13(5): 583 doi: 10.1007/s11523-018-0589-7
|
| 91 |
Nourhan Hossam, Marwa Matboli, Hanan H. Shehata, Marwa M. Aboelhussein, Mohamed Kamel Hassan, Sanaa Eissa. Toll-like receptor immune modulatory role in personalized management of colorectal cancer, review of literature. Expert Review of Precision Medicine and Drug Development 2020; 5(6): 455 doi: 10.1080/23808993.2020.1816136
|
| 92 |
Timsy Uppal, Roni Sarkar, Ranjit Dhelaria, Subhash Verma. Role of Pattern Recognition Receptors in KSHV Infection. Cancers 2018; 10(3): 85 doi: 10.3390/cancers10030085
|
| 93 |
Jing Zhang, Limei Shen, Xiang Li, Wantong Song, Yun Liu, Leaf Huang. Nanoformulated Codelivery of Quercetin and Alantolactone Promotes an Antitumor Response through Synergistic Immunogenic Cell Death for Microsatellite-Stable Colorectal Cancer. ACS Nano 2019; 13(11): 12511 doi: 10.1021/acsnano.9b02875
|
| 94 |
Tianqi Liu, Yining Liu, Xiangqian Su, Lin Peng, Jiangbo Chen, Pu Xing, Xiaowen Qiao, Zaozao Wang, Jiabo Di, Min Zhao, Beihai Jiang, Hong Qu. Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer. Computers in Biology and Medicine 2023; 153: 106545 doi: 10.1016/j.compbiomed.2023.106545
|
| 95 |
O. I. Kit, E. A. Dzhenkova, E. A. Mirzoyan, A. B. Sagakyants, E. Yu. Zlatnik, E. S. Bondarenko, I. A. Novikova, A. A. Maslov. Comparative analysis of some immunological parameters depending on the tumor location on the right and left sides of colon. Innovative Medicine of Kuban 2022; (3): 20 doi: 10.35401/2541-9897-2022-25-3-20-28
|
| 96 |
Jie Guo, Mengfan Liao, Jun Wang. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155. Cell Communication and Signaling 2021; 19(1) doi: 10.1186/s12964-021-00771-6
|